More efficient rare pediatric drug development: FDA drafts guidance
The FDA on Wednesday released a draft guidance that could help speed the development of treatments for rare pediatric disease drugs.
Janet Woodcock, director …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
